MERILYN TUNSTALL-STROMAN: Open Payments
NPI 1336525203 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,852 in 81 payments from 32 companies in 2025. Trend: 2023 $635 · 2024 $972 · 2025 $2,852
Food & beverage: $2,474Long term medical supply or device loan: $199Education: $179
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $424 |
| Daiichi Sankyo Inc. | 9 | $404 |
| Novartis Pharmaceuticals Corporation | 6 | $272 |
| AstraZeneca Pharmaceuticals LP | 8 | $269 |
| GlaxoSmithKline, LLC. | 3 | $258 |
| Janssen Biotech, Inc. | 9 | $250 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114 |
| PFIZER INC. | 4 | $99 |
| SEAGEN INC. | 1 | $80 |
| Verity Pharmaceuticals Inc. | 4 | $67 |
Products named: Enhertu, MONJUVI, KISQALI, RYBREVANT, OJJAARA, JEMPERLI, Nubeqa, Trelstar.
Industry payments across TX — which companies pay providers there.
